About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,818 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,818 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3281-3300 of 10,818 trials

CompletedPatient Sleep Position QuestionnaireYou are being asked to participate in this study because we would like to know if sleeping may affect eye pressure.NCT00338013·Nashville, Tennessee Active not recruitingBeamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard TreatmentThis study is open to adults 18 years and older with advanced or metastatic non-small cell lung cancer.NCT06151574·Huntsville, Alabama and 162 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

CompletedA Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer ParticipantsThis randomized, active controlled, multicenter phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with crizotinib treatment in…NCT02075840·Northridge, California and 96 others

CompletedA Study of INCAGN01876 in Participants With Advanced or Metastatic Solid TumorsThis was an open-label, non-randomized Phase 1/2 safety study of INCAGN01876 in participants with advanced or metastatic solid tumors that was conducted in 2 parts.NCT02697591·Los Angeles, California and 7 others

RecruitingMOdification Of THe Early-Life Respiratory Microbiome Through Vaginal SEEDingThis is a single-center, parallel-arm, blind, sham-controlled, feasibility randomized controlled trial (RCT) to be conducted in healthy cesarean-born children.NCT05505110·Nashville, Tennessee

CompletedSafety and Clinical Performance of the Protecta ICD and CRT-DThe purpose of the study is two-fold. In Phase I (Protecta Clinical Study), system performance will be evaluated.NCT00982397·Birmingham, Alabama and 121 others

CompletedNeurophysiology and Anatomy of Severe Intraventricular Hemorrhage (IVH)Currently, when premature infants develop severe intraventricular hemorrhage (IVH), a type of intracerebral bleed, there are no proven therapeutic interventions to prevent the…NCT00817310·Nashville, Tennessee

Active not recruitingA Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast CancerThis study is being done to see if tucatinib works better than placebo when given with other drugs to treat participants with HER2-positive breast cancer.NCT05132582·Phoenix, Arizona and 306 others

TerminatedVEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine TumorsThis study is to evaluate the combination of an investigational drug X-82 with everolimus in the treatment of pancreatic neuroendocrine tumors.NCT01784861·St Louis, Missouri and 1 other

Active not recruitingStudy of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)This is a randomized, double-blind, multi-center, global Phase II study to determine the efficacy and safety of Durvalumab plus Olaparib combination therapy compared with…NCT03775486·Bonita Springs, Florida and 67 others

TerminatedNew Formulations of Propafenone to Treat Atrial FibrillationPropafenone is a currently used medicine to treat atrial fibrillation and is a mixture of two compounds, (R)-propafenone and (S)-propafenone.NCT02710669·Nashville, Tennessee

CompletedPRospective Study Of MammaPrint in Patients With an Intermediate Recurrence ScoreThis is a prospective study that will assess the impact of MammaPrint on chemotherapy + endocrine versus endocrine alone treatment decisions in patients with an Oncotype…NCT01617954·Phoenix, Arizona and 52 others

Active not recruitingA Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 TabletsMultiple myeloma (MM) is a plasma cell disease characterized by the growth of clonal plasma cells in the bone marrow.NCT05308654·Stanford, California and 20 others

CompletedA Study of Retatrutide (LY3437943) in Participants Who Have Obesity or OverweightThe purpose of this study is to evaluate the efficacy and safety of retatrutide in participants who have obesity or overweight (J1I-MC-GZBJ master protocol) including subsets of…NCT05929066·Phoenix, Arizona and 133 others

CompletedEfficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic AsthmaA substance called immunoglobulin E (IgE), which is naturally produced by our body, has a key role in generating asthma attacks.NCT00079937·Birmingham, Alabama and 55 others

CompletedSafety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) PatientsThis double-blind, placebo-controlled, randomized study is designed to evaluate the safety and therapeutic effects of sapropterin dihydrochloride on neuropsychiatric symptoms in…NCT01114737·La Jolla, California and 35 others

CompletedLenalidomide With or Without Rituximab After Standard Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin LymphomaRATIONALE: Lenalidomide may stop the growth of cancer cells by blocking blood flow to the cancer.NCT00765245·Chapel Hill, North Carolina and 3 others

CompletedA Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset SeizuresThe goal of this clinical trial is to learn if CVL-865, when taken regularly with other anti-seizure medicines, works to prevent seizures in adults with drug-resistant focal onset…NCT04244175·Little Rock, Arkansas and 75 others

RecruitingSafety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related ComorbiditiesObesity is a condition where a person has excessive body fat, defined by a body mass index (BMI) of 30 kg/m2 or higher.NCT07752979·Pelham, Alabama and 53 others

RecruitingA Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)This three-arm randomized phase 2 trial will enroll advanced clear cell RCC patients (all IMDC risk groups).NCT07188896·Washington D.C., District of Columbia and 4 others

PreviousPage 165 of 541Next

Diabetes

in Nashville

Heart Diseasein Nashville